Another method that can potentially increase the diagnostic accuracy in biochemical recurrence of PCa is [68Ga]PSMA-11 PET-MRI, which combines the high performance of PSMA-PET for whole body assessment with the multiparametric potential and high soft tissue contrast of MRI, well suited to the locoregional evaluation of the prostate bed and pelvis. The gene discussed is FOLH1; the disease is posterior cortical atrophy.